Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

36,672 stories, page 163 of 612

Advanced search

🇺🇰Aug 27Regulatorygov.ukTier 1 · Regulatory source

Cover of vaccination evaluated rapidly (COVER) programme: April 2024 to March 2025

Official statistics annual data on coverage achieved by the childhood immunisation programme in Engl...

UK Health Security AgencyOriginal source

🇺🇰Aug 27Regulatorygov.ukTier 1 · Regulatory source

Vaccine prospectus: National Immunisation Programme and vaccine products

The vaccine prospectus sets out the work that UKHSA and the wider health family do to sustain and gr...

UK Health Security AgencyOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical: Cameroon lagging behind Senegal, Tunisia, and Morocco

Financial AfrikOriginal source

🌍Aug 27Industryproqr.comTier 1 · Company source

Meet Anne Geert Volbeda - Associate Director, Drug Substance Development and Manufacturing

ProQROriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

CSPC Pharmaceutical Group (SEHK:1093) Rallies Following Strong H1 Results As Valuation Stays In Focus

simplywall.stOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Yongan Pharmaceutical (002365.SZ) announced its semi-annual results, with net profit attributable to shareholders of RMB 43.4083 million, a year-on-year increase of 247.39%.

google_newsOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

191,578 Shares in Ultragenyx Pharmaceutical Inc. $RARE Acquired by Connor Clark & Lunn Investment Management Ltd.

MarketBeatOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Europe Biopharmaceutical Contract Manufacturing Market Size, Share,Trends, Growth Analysis Report, 2030

MarketsandMarketsOriginal source

🇺🇰Aug 27Researchukri.orgTier 2 · Direct publisher

Spin-out technology promises to cut costs of protein production

Medical Research Council (UKRI)Original source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Moderna cancer vaccine "one shot $500,000" is a misreading — $475,000 is actually a per-course valuation assumption

finance.biggo.comOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Turkey Competition Authority investigates Teva for alleged drug market antitrust

The Jerusalem PostOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Greece, Poland urge Irish EU presidency to advance biotech and medicines security

euractiv.comOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Daewoong Pharmaceutical Secures U.S. Patent Approval for Core Anti-Aging mRNA Delivery Technology

finance.biggo.comOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Tezspire Hits Both Primary Endpoints in Phase 3 Eosinophilic Esophagitis Trial

The Clinical Trial VanguardOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Amgen's Tezspire improved swallowing and esophageal inflammation for 52 weeks

Stock TitanOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Marquis Who's Who Honors Bernard D. Santarsiero for Expertise in Pharmaceutical Sciences, Structural Biology, Structural Chemistry, and Crystallography

24-7PressRelease.comOriginal source

🇪🇸Aug 27Regulatoryaemps.gob.esTier 1 · Regulatory source

La AEMPS informa de un posible defecto de fabricación en la sonda intermitente uretral hidrofílica Onli

AEMPS (Spain)Original source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Spurned Lover Exposes Maharashtra FDA Drug Inspector Exam Paper Leak

streamlinefeed.co.keOriginal source

🌍Aug 27Industryhealth.ucdavis.eduTier 1 · Company source

Betty Irene Moore Fellows convene in the nation’s capital for seventh convocation

UC Davis HealthOriginal source

🌍Aug 27Industryhealth.ucdavis.eduTier 1 · Company source

Ready to take control of your breathing? Register for the UCAN Bootcamp

UC Davis HealthOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

FDA approves landmark pancreatic cancer drug that's shown to improve survival

88.5 WFDDOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Asset Value Investors Raises Stake In Wakamoto Pharmaceutical Co Ltd To 11.64% From 10.60%, Filing Shows

TradingViewOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Generate Biomedicines’ GB-0895 Phase 1 Data Released Early Ahead of ERS Presentation

The Clinical Trial VanguardOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

3 Japanese AI Healthcare Stocks With Real World Revenue

simplywall.stOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

XBIUSD.P Charts and Quotes

TradingViewOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Jinling Pharmaceutical Co., Ltd. Class A – SZSE:000919

TradingViewOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy

TradingViewOriginal source

🇨🇭Aug 27Industryinterpharma.chTier 1 · Company source

Medienmitteilung: US-Pharmapolitik birgt Milliardenrisiken für die Schweiz: Szenarioanalyse zeigt bis zu 195 Mrd. Franken weniger Wertschöpfung bis 2040

Interpharma SwitzerlandOriginal source

🇯🇵Aug 27Industrynewsroom.astellas.comTier 1 · Company source

Astellas Becomes Host City Partner for One Young World 2027 Tokyo Summit

Astellas PharmaOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

DKSH to Buy Thai Pharmaceutical Ingredients Distributor PR Chemicals

marketscreener.comOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

BRAIN Biotech reports its 9M results and continues to target a break-even adjusted Group-EBITDA

TradingViewOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Daewoong secures US patent allowance for anti-aging mRNA technology

The Korea HeraldOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA explained: Tukaram Mundhe’s role and powers

Storyboard18Original source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Biotech Growth Trust PLC – LSE:BIOG

TradingViewOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Monod Bio licenses AI-designed protein technologies to SignalChem Biotech for custom discovery assays

News-MedicalOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Countdown to BIOHK2026: World-Class Biotech Convention Prepares to Host Global Pavilions, Multi-Track Forums, and Signature Executive Networking

PR NewswireOriginal source

🇺🇸Aug 27Regulatoryfda.govTier 1 · Regulatory source

Early Alert: Esophageal pH Monitoring Capsule Delivery Device Issue from Medtronic and Given Imaging

The Medtronic and Given Imaging Bravo CF esophageal pH monitoring capsule can fail to attach to the...

FDA MedWatchOriginal source

🇺🇸Aug 27Regulatoryfda.govTier 1 · Regulatory source

Convenience Kit Correction: AVID Medical Issues Correction for Kits Containing Medline Namic Star Off Handle Manifolds

AVID Medical is correcting convenience kits containing Manifolds affected by the Medline Namic Angio...

FDA MedWatchOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Genscript Biotech (SEHK:1548) On Widening Losses And Falling Sales Still Looks Pricey

simplywall.stOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

US FDA Approves Drug That Could Extend Survival In Metastatic Pancreatic Cancer

GujaratSamachar EnglishOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth

TradingViewOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Dimerix banks US$10m upfront Everest payment

The AustralianOriginal source

🇺🇸Aug 27Industry4gclinical.comTier 1 · Company source

Supply Had to Respond to Live Reality - Science in Motion Series

4G ClinicalOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Argenica Therapeutics (ASX:AGN) Stroke Drug Clears FDA-Requested Safety Tests and Posts a New Neuroprotection Signal

KalkineOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

mFlusiva becomes the first mRNA influenza vaccine approved by the FDA

2 Minute MedicineOriginal source

🇺🇸Aug 27Industrythefdalawblog.comTier 3 · Secondary coverage

A Costly 180: The D.C. Circuit Flips FDA’s Forfeiture Playbook

Hyman, Phelps & McNamara (FDA Law)Original source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial

South China Morning PostOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Oxygenta Pharmaceutical Limited – BSE:OXYGENTAPH

TradingViewOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Julius Baer’s Jeffrey Tam: Diversify equities with financials and biotech

fundselectorasia.comOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Is Burning Rock Biotech Ltd (BNR) Overvalued After 6.5% Rally? G

GuruFocusOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Caliway Secures FDA IND Clearance for CBL-514–Tirzepatide Phase 2 Trial, Advances SUPREME-01 Phase 3

BioPharma APACOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Argent BioPharma takes CannEpil into US veterinary regulatory process

BiotechDispatchOriginal source

🌍Aug 27discoverynews.google.comTier 3 · Aggregated media

Cancer drug sales power up Kelun-Biotech’s profit engine

thebambooworks.comOriginal source

🇺🇸Aug 27Regulatorysec.govTier 1 · Regulatory source

AstraZeneca filed Form 6-K

SEC EDGAROriginal source

🇺🇸Aug 27Regulatorysec.govTier 1 · Regulatory source

BioNTech filed Form 6-K

SEC EDGAROriginal source

🇯🇵Aug 27Researchkyoto-u.ac.jpTier 2 · Direct publisher

Notice regarding advertisements for new residents issued under the name of the “Yoshida-Ryo Resident Student Association”

Kyoto UniversityOriginal source

🇺🇸Aug 27Regulatoryfederalregister.govTier 1 · Regulatory source

Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV

On May 29, 2026, the United States Food and Drug Administration (FDA) approved a new drug applicatio...

Federal RegisterOriginal source

🇺🇸Aug 27Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Notice of Closed Meetings

Federal RegisterOriginal source

🇺🇸Aug 27Regulatoryfederalregister.govTier 1 · Regulatory source

Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act

The Drug Enforcement Administration (DEA) issues this temporary order to schedule 1-(1-(1-(4-bromoph...

Federal RegisterOriginal source

🇺🇸Aug 27Regulatoryfederalregister.govTier 1 · Regulatory source

Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Second Extension of Effective Date of Final Resolution of Drug Efficacy Study Implementation 7661

The Food and Drug Administration (FDA or Agency) is extending the effective date of the notice publi...

Federal RegisterOriginal source